Health
Peptides For Post-Surgical Healing After Rhinoplasty
While rhinoplasty procedures vary in complexity and expected recovery times, everyone wants to heal faster and minimise downtime after the procedure. The success of the procedure to reduce pore size will not only depend on the skill of the surgeon but also the patient’s ability to heal properly.
In the past few years, a group of molecules, known as peptides, have increasingly gained significant attention in the medical field for their incredible potential in bolstering the healing process. Simply put, they are a group of naturally occurring or synthetic amino acids that have been shown to optimise healing and recovery times.
Let’s take a deeper look at peptides, how they work, their benefits, and how they can be used in post-surgical recovery after rhinoplasty.
How Peptides Enhance Healing
Before discussing the role of peptides in rhinoplasty healing, it’s vital to understand the healing process following a rhinoplasty procedure. Rhinoplasty typically involves the manipulation of nasal tissues, which includes cartilage, skin, and bone. Once the procedure is complete, the body will naturally undergo a sequence of healing events:
Inflammation – The body will first respond to the surgical trauma by triggering an inflammatory response. This is essential for clearing away any damaged tissue to start the healing process.
Proliferation – The body then starts to produce new blood vessels and initiates the formation of granulation tissue. During this stage, collagen production will increase to help rebuild the damaged tissue.
Remodeling – The final stage entails remodeling the newly formed tissue, including collagen. The scar tissue will gradually mature and gain strength.
The quality of healing will have a direct impact on the functional and aesthetic outcome of the rhinoplasty procedure. Improper or inadequate healing may lead to complications like poor nasal shape, scarring, and even breathing difficulties. This is where peptides come in.
Peptides mainly serve as signaling molecules, orchestrating a number of biological processes needed for healing and recovery. They do this by influencing various biological actors, including cytokines, growth factors, and immune cells. For instance, growth factors are needed for cell differentiation and cell proliferation, which are critical to tissue regeneration and wound healing.
Besides this, they influence cytokines, which play a critical role in regulating inflammation. Peptides such as TB-500 and BPC-157 can help control pain and inflammation associated with rhinoplasty by regulating the production of cytokines. They also influence immune system cells, which are responsible for not only protecting the body from infection but also facilitating tissue repair.
According to peptidesireland.com, some peptides have been shown to influence protein synthesis and the metabolism of fat, both of which have a vital impact on post-rhinoplasty recovery. By enhancing protein synthesis, peptides help with the repair of damaged tissues, and by optimising fat metabolism, they help with the overall healing and energy balance.
Benefits of Using Peptides for Healing
Using peptides for tissue repair has several potential benefits
Faster healing: Peptides can quicken the healing process, essentially shortening the recovery time from the rhinoplasty procedure. Faster healing means less discomfort, less downtime, and a faster return to normalcy.
Less pain and inflammation: Since peptides are naturally occurring in the body, they are usually well-tolerated with minimal side effects. While each peptide has its unique benefits, many will have anti-inflammatory properties, which can help alleviate pain associated with surgical procedures.
Antimicrobial properties: Peptides with antimicrobial properties, like LL-37, can help lower the risk of postoperative infections, which is a common concern following surgery.
Improved Angiogenesis: Peptides such as fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) help promote the formation of new blood vessels. They can help improve blood flow to the site of the wound, making sure there’s enough supply of oxygen and nutrients, which is vital for tissue healing.
Clinical Applications of Peptides in Rhinoplasty Healing
Although research is still ongoing when it comes to the application of peptides to heal rhinoplasty surgery, there are a few promising developments:
Topical peptide formulas: Topical peptide formulations may be used on the incision site to help stimulate the production of collagen and reduce scarring. The formulations are usually applied during the postoperative care period.
Injectable peptides: Some peptides are administered via injections to help target specific areas of the nose that might require additional healing support. This approach will essentially allow for more precise and tailored treatment.
Oral supplements: For some cases, oral supplements that contain peptides may be recommended to help promote overall healing from within.
Risks and Challenges of Using Peptides
While peptides offer great promise in enhancing rhinoplasty healing, there are several challenges to address. For starters, the efficacy and safety of certain peptides for postoperative care still need further investigation, and patient-specific elements should be considered in treatment plans.
As for the potential side effects, some patients may experience nausea, headache, or allergic reactions following peptide administration. These side effects will vary greatly from patient to patient and will be dependent on several factors, including the kind of peptide used, the amount of dose administered, and the overall health of the patient.
It’s also worth noting that while peptides are legal in many jurisdictions, some are considered performance-enhancement substances, and are therefore prohibited in certain sports. The potential misuse of peptides in industries such as bodybuilding and athletics also raises safety and ethical concerns.
Final Thoughts
The use of peptides to help with healing after rhinoplasty presents an exciting frontier in cosmetic surgery. By enhancing quality healing, peptides have the potential to lead to better functional and aesthetic outcomes.
Nonetheless, it’s still important to note that the field is still evolving, and further clinical research is needed to establish the safety and efficacy of certain peptide treatments.
By Modupe Gbadeyanka
As part of its efforts to safeguard public health in Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) has strengthened its regulatory framework for blood and blood products.
A statement signed on Thursday by the Director General of NAFDAC, Prof Mojisola Adeyeye, disclosed that to achieve its goal, the agency will collaborate with relevant authorities and stakeholders to establish a robust regulatory framework that promotes the availability of safe, quality-assured and efficacious blood and blood products, while strengthening public confidence in Nigeria’s healthcare system.
NAFDAC said it intends to partner with government institutions, healthcare providers, blood establishments, development partners and other stakeholders for the robust oversight.
Mrs Adeyeye disclosed that already, her organisation has received the support of the Minister of Health and Social Welfare, Prof Ali Pate.
According to her, NAFDAC has been given the mandate to regulate blood and blood products in line with global best practices and the World Health Organisation (WHO) recommendation that these products be subject to oversight by National Regulatory Authorities (NRAs) for medicines.
She said blood and blood products are classified as essential medicines and must be consistently available with assured quality, safety and affordability, stressing that the aim is to protect patients throughout the blood transfusion chain.
Effective regulatory oversight will support the quality and safety of blood products from donor assessment and collection through testing, processing, storage, transportation and use, the NAFDAC chief noted.
Several African countries, including Egypt, Ghana, South Africa, Tanzania, Zimbabwe, Senegal and Rwanda, have already established regulatory oversight of blood and blood products by their NRAS, she added.
Mrs Adeyeye pointed out that NAFDAC’s renewed regulatory preparedness builds on its broader transformation into a modern, science-based regulatory authority.
Already, it has attained WHO Maturity Level 3, completed WHO Global Benchmarking ML3 re-assessment, obtained WHO prequalification for its drug laboratory, and established internationally accredited laboratory and quality management systems. These capabilities provide a strong foundation for the effective regulation of blood and blood products.
As part of its preparedness, NAFDAC has established a dedicated Vaccines, Biologicals and Medical Devices Registration and Regulation Directorate to oversee the registration and regulation of these products.
The agency established a Vaccines, Biologicals and Medical Devices Laboratory Services many years ago, but became a Directorate in 2024, responsible for quality control, including laboratory testing and lot release, while the Directorate of Evaluation and Research provides oversight of Good Manufacturing Practices. An ultra-modern laboratory facility is also being developed to further strengthen its capacity for the assessment and quality control of vaccines and biologics.
By Modupe Gbadeyanka
An organisation known as GoMed Nigeria is offering free reproductive health services to Nigerian students through a digital self-care platform.
This is being delivered through a partnership with the United Nations Population Fund (UNFPA) and the Lagos State Government.
The pilot scheme will be available to students of the University of Lagos. They will enjoy easier and more private access to essential health products, accurate information, and professional support.
Young Nigerians face some of the highest rates of unintended pregnancy and unmet need for contraception in the world.
Cost, distance, stigma, misinformation, and fears about confidentiality routinely stop students from seeking the products and guidance they need, with consequences that include unintended pregnancy, unsafe abortion, sexually transmitted infections and interrupted education.
The self-care platform is designed to remove each of these barriers. Through the platform, students receive free contraceptives and other sexual and reproductive health commodities provided through the Lagos State Ministry of Health and UNFPA, exclusive discounts on health essentials, and fast, discreet delivery directly to campus and student hostels.
Students can also access trusted sexual and reproductive health information and services through UNFPA’s SoftLife 247 and U-Plan platforms. Through U-PLAN, they can chat directly with qualified Family Planning Service Providers to receive accurate information and address their concerns. They can also confidently engage with GoMed’s registered pharmacists for confidential, judgement-free guidance on medicines and other health products.
“Students should be able to get reliable health information and essential products without cost, distance or fear of judgement becoming barriers.
“This platform brings free sexual and reproductive health commodities, other affordable health products and professional guidance together, with discreet delivery directly to students on campus,” the chief executive of GoMed Nigeria, Mr Anthony Edeki, said.
Also speaking, UNFPA in Nigeria Resident Representative, Muriel Mafico, said, “As the UN agency mandated for “Sexual and Reproductive Health and Rights”, we are committed to reducing preventable maternal deaths and addressing the unmet need for family planning, including by providing and overseeing access to life-saving commodities worldwide.
“Working alongside our partners, we’re helping roll out the digital Self-Care Platform—so that vital, life-changing information can reach more people, more easily. Together, we want to empower Nigeria’s next generation to make informed health choices and achieve stronger health outcomes and a brighter future.”
By Modupe Gbadeyanka
A financing framework to accelerate the electrification of health facilities nationwide has been approved by the federal government.
The approval was announced at the third meeting of the Inter-Ministerial Steering Committee (IMSC) of the Nigeria Power for Health Initiative (NPHI), a presidential programme jointly coordinated by the Federal Ministries of Power and Health and Social Welfare.
The committee was constituted to ensure reliable electricity in at least 30 per cent of Nigeria’s health facilities by the end of 2027.
At the meeting, chaired by the Minister of State for Health and Social Welfare, Mr Isiaq Salako, and co-chaired by the Minister of Power, Mr Joseph Tegbe, members of the Inter-Agency Technical Committee (IATC) presented the recommendations under consideration.
Speaking at the meeting, Mr Salako said the Steering Committee approved a financing framework to mobilise investment for healthcare electrification, alongside a facility energy management framework requiring participating hospitals to build sustainable systems for managing their energy infrastructure.
He said the committee also cleared eight (8) private sector proposals for further engagement, drawn from about 70 submissions received during the National Healthcare Electrification Investor Matchmaking Week in Lagos.
The Health Minister added that Energy Management Teams are already in place at federal tertiary hospitals, with state governments being encouraged to set up similar structures. The initiative will now be institutionalised through dedicated budgetary provisions and a full-time Project Coordination Unit to oversee implementation.
On his part, Mr Tegbe declared that the initiative must now move from announcements to actual project delivery.
Describing the NPHI as one of the President Bola Tinubu administration’s flagship programmes, he said the emphasis should shift towards commissioning completed projects that Nigerians can see for themselves, rather than further groundbreaking ceremonies and public messaging.
He emphasised the need for teaching hospitals, state hospitals, and primary healthcare centres to be fully energised, noting that the Rural Electrification Agency has already energised 5 Federal Teaching Hospitals and several other health facilities nationwide.
He also tied the initiative directly to patient outcomes, arguing that dependable power would end hospitals’ reliance on emergency generators, and pledged that the Ministry would continue to prioritise the initiative’s funding needs while ensuring value for money.
